Earth Science Tech (ETST) Depreciation & Amortization - Total (2023 - 2026)
Earth Science Tech's (ETST) quarterly Depreciation & Amortization - Total came in at $60399.0 in Q2 2026, up 74.75% on a YoY basis from $34563.0 in Q2 2025, and up 2.24% quarter-over-quarter from $59074.0 in Q1 2026.
Powered by 
Analysis
Earth Science Tech (ETST) Depreciation & Amortization - Total (2023 - 2026) Analysis & Trends
Earth Science Tech (ETST) has reported Depreciation & Amortization - Total for 4 consecutive years, with $60399.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Depreciation & Amortization - Total rose 74.75% year-over-year to $60399.0; the trailing twelve-month figure through Jun 2026 stood at $246957.0 (up 269.86% YoY), and the FY2026 full-year result was $219862.0, up 399.71% from the prior year.
- Depreciation & Amortization - Total improved to $60399.0 in Q2 2026 per ETST's latest filing, from $59074.0 in the prior quarter.
- Across five years, Depreciation & Amortization - Total topped out at $77391.0 in Q3 2025 and bottomed at $5638.0 in Q1 2024.
- Historically, Depreciation & Amortization - Total has averaged $31185.9 across 4 years, with a median of $14373.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization - Total slumped 78.23% in 2024, then soared 567.05% in 2025.
- Over 4 years, Depreciation & Amortization - Total stood at $14373.0 in 2023, then fell by 18.62% to $11697.0 in 2024, then soared by 328.26% to $50093.0 in 2025, then increased by 20.57% to $60399.0 in 2026.
- According to Business Quant data, Depreciation & Amortization - Total over the past three periods registered $60399.0, $59074.0, and $50093.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | - |
| 10 | Earth Science Tech | 25.88 Mn | 23.09 Mn | 6.28 Mn | 60,399.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60,399.00 |
| Mar 31, 2026 | 59,074.00 |
| Dec 31, 2025 | 50,093.00 |
| Sep 30, 2025 | 77,391.00 |
| Jun 30, 2025 | 34,563.00 |
| Mar 31, 2025 | 8,908.00 |
| Dec 31, 2024 | 11,697.00 |
| Sep 30, 2024 | 11,602.00 |
| Jun 30, 2024 | 10,999.00 |
| Mar 31, 2024 | 5,638.00 |
| Dec 31, 2023 | 14,373.00 |
| Sep 30, 2023 | 53,301.00 |
| Jun 30, 2023 | 7,379.00 |